Dr. Nikhil Kothari, MD

Dr. Kothari practices at Temple University Hospital - Main Campus in Philadelphia, Pennsylvania.

Dr. Kothari's NPI, 1306225388, was assigned on May 25, 2015. Dr. Kothari holds New Jersey license 25MA10881300.

Dr. Kothari's primary practice is Temple University Hospital - Main Campus, at 3401-41 N Broad St, Philadelphia, PA 19140 in Philadelphia County. The practice phone is (215) 707-5303.

Dr. Kothari's primary practice is Temple University Hospital - Main Campus in Philadelphia, Pennsylvania. Dr. Kothari is also affiliated with Virtua Voorhees Hospital. The medical group on file is Mount Sinai Institute for Liver Medicine. Dmand AI also links Dr. Kothari to 2 more hospitals and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kothari practices, 3 sites in all. Vendor and product names are available with a free account.

Hospitalist is Dr. Kothari's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dmand AI has Dr. Kothari's licenses on file in 3 states: New Jersey, New York and Pennsylvania.

CMS data shows 439 Medicare services from Dr. Kothari across 4 procedure codes in 2024, for 187 Medicare patients. Medicare paid $39,916 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 187 Medicare patients who saw Dr. Kothari in 2024. The largest group is 75 to 84, with 61 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 32% are also on Medicaid. Their average risk score is 2.49, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kothari's median patient age at 65, with 51% women.

In 2024, Dr. Kothari wrote 393 Medicare Part D claims for 130 patients. 83% of them were for generic drugs. CMS names the drug for 195 of them, across 8 drugs with 11 or more claims each, at $22,712 in total drug cost. In 2023, CMS named 100 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Kothari for performance year 2024, reported as part of a group. Dr. Kothari accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kothari as offering telehealth.

Dmand AI links 89 papers to Dr. Kothari, published from 2011 to 2025. 2022 was the busiest year, with 11. The most frequent topics are Anti-Bacterial Agents, Catheterization, Peripheral and Intensive Care Units. Dr. Kothari has published most often in Indian J Crit Care Med. Dr. Kothari's most frequent co-authors are Ankur Markand Sharma, MD, Amit Goyal, MD and Mohammed Alsabri Hussein Alsabri, MD.

CMS Open Payments shows 2 general payments to Dr. Kothari from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Ceribell, Inc. paid the most, $112.